Impact of nutritional intervention with vitamin K2 bone turnover markers in healthy indian premenopausal women (25-45 yrs; inclusive): Study design and nutritional bone health biomarkers strategy

2018 ◽  
Vol 08 ◽  
Author(s):  
Pankaj Verma
Keyword(s):  
Bone Turnover ◽  
Study Design ◽  
Bone Health ◽  
Bone Turnover Markers ◽  
Premenopausal Women ◽  
Nutritional Intervention ◽  
Vitamin K2 ◽  
Turnover Markers

Reference intervals of bone turnover markers in healthy premenopausal women: Results from a cross-sectional European study

Bone ◽  
2012 ◽  
Vol 50 (5) ◽  
pp. 1141-1147 ◽  
Author(s):  
Richard Eastell ◽  
Patrick Garnero ◽  
Christine Audebert ◽  
David L. Cahall
Keyword(s):  
Bone Turnover ◽  
Bone Turnover Markers ◽  
Premenopausal Women ◽  
Reference Intervals ◽  
European Study ◽  
Cross Sectional ◽  
Turnover Markers

Determinants of Bone Turnover Markers in Healthy Premenopausal Women

2008 ◽  
Vol 82 (5) ◽  
pp. 341-347 ◽  
Author(s):  
Silvano Adami ◽  
Gerolamo Bianchi ◽  
Maria Luisa Brandi ◽  
Sandro Giannini ◽  
Sergio Ortolani ◽  
...  
Keyword(s):  
Bone Turnover ◽  
Bone Turnover Markers ◽  
Premenopausal Women ◽  
Turnover Markers

SAT0486 Reference Intervals for Bone Turnover Markers in Spanish Premenopausal Women

2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 769.1-769
Author(s):  
N. Guañabens ◽  
X. Filella ◽  
A. Monegal ◽  
C. Gomez-Vaquero ◽  
M. Bonet ◽  
...  
Keyword(s):  
Bone Turnover ◽  
Bone Turnover Markers ◽  
Premenopausal Women ◽  
Reference Intervals ◽  
Turnover Markers

scholarly journals Bone health in cerebral palsy and introduction of a novel therapy

2015 ◽  
Vol 13 (4) ◽  
pp. 555-559 ◽  
Author(s):  
Morton Aaron Scheinberg ◽  
Ricardo Prado Golmia ◽  
Adriana Maluf Elias Sallum ◽  
Maria Guadalupe Barbosa Pippa ◽  
Aline Pinheiros dos Santos Cortada ◽  
...  
Keyword(s):  
Cerebral Palsy ◽  
Bone Turnover ◽  
Bone Health ◽  
Bone Turnover Markers ◽  
Human Monoclonal Antibody ◽  
Mineral Density ◽  
Novel Therapy ◽  
Disability Score ◽  
Children With Cerebral Palsy ◽  
Turnover Markers

ABSTRACT Objective To assess the bone health status of children with cerebral palsy and the therapeutic effect of denosumab in a subgroup of children with cerebral palsy and decreased bone mass. Methods Children with cerebral palsy were evaluated according to their motor disability score (classification system gross motor functions III to V), bone density and bone turnover markers. Dual X-ray energy absorption was used to measure the lumbar spine, and total body, except the head. Thereafter a group of children with cerebral palsy and osteoporosis was treated with denosumab, a fully human monoclonal antibody. Bone turnover markers were measured before and three months after treatment. Results Reduction in bone mineral density was observed, particularly in children with greater impairment evaluated by the motor score. Decreased bone turnover markers were found in a selected group of children three months after exposure to denosumab. Conclusion Bone loss was present in children with significant impairment of motor function, as well as decreased serum levels of bone resorption markers with new forms.

Sign in / Sign up

Export Citation Format

Share Document